AVIGEN
Avigen, Inc., a biopharmaceutical company, engages in identifying and developing products to treat patients with neurological and other disorders. The company develops the AV411 portfolio, which includes the phase II-stage lead drug compound and proprietary analogs and represents novel, non-opioid drugs for the treatment of various large pain and drug addiction indications. AV411 is an orally bioavailable small molecule; a glial attenuator that suppresses pro-inflammatory cytokines IL-1 beta, TN... F alpha, and IL-6; and a toll-like receptor 4 (TLR4) functional antagonist that may contribute to its attenuation of neuroinflammation. AV411 is being evaluated in Phase Ib/IIa clinical trials. The company was founded in 1992 and is headquartered in Alameda, California. As of December 18, 2009, Avigen, Inc. operates as a subsidiary of MediciNova Inc
AVIGEN
Social Links:
Industry:
Biotechnology Health Diagnostics
Founded:
1992-01-01
Address:
Huntsville, Alabama, United States
Country:
United States
Website Url:
http://www.en.aviagen.com
Total Employee:
1001+
Status:
Active
Contact:
256 890 3800
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics Content Delivery Network Google Universal Analytics Nginx Amazon IPv6 ReCAPTCHA
Similar Organizations
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Official Site Inspections
http://www.en.aviagen.com
- Host name: aviagen.com
- IP address: 104.130.207.90
- Location: Chicago United States
- Latitude: 41.9025
- Longitude: -87.6726
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60622
